name,category,termsATPase type 13A1,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005967$IPR006544:ATPase, P-type, unknown pump specificity (type V), 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase type 13A1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane]
ATPase type 13A1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850041311$chain:Probable cation-transporting ATPase 13A1, 850102565$compositionally biased region:Poly-Ala, 850102566$compositionally biased region:Poly-Arg, 850105770$glycosylation site:N-linked (GlcNAc...), 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
DnaJ (Hsp40) homolog, subfamily A, member 1,INTERPRO[450001150$IPR001305:Heat shock protein DnaJ, cysteine-rich region, 450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002592$IPR002939:Chaperone DnaJ, C-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily A, member 1,PIR_SUPERFAMILY[630002699$PIRSF002585:heat shock protein DnaJ]
DnaJ (Hsp40) homolog, subfamily A, member 1,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily A, member 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000288$Chaperone, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001236$prenylation, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
DnaJ (Hsp40) homolog, subfamily A, member 1,UP_SEQ_FEATURE[850016139$chain:DnaJ homolog subfamily A member 1, 850102517$compositionally biased region:Gly-rich, 850104487$domain:J, 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850106259$mutagenesis site, 850115822$repeat:CXXCXGXG motif, 850117294$sequence conflict, 850118793$zinc finger region:CR-type]
Janus kinase 2,BBID[10000019$12.IL-6_type_cytok-signal-transduct, 10000069$48.mice_minus_JAKs_and_STATs, 10000096$75.Stats_activators_of_Apoptosis]
Janus kinase 2,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000099$h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB, 30000100$h_epoPathway:EPO Signaling Pathway, 30000125$h_ghPathway:Growth Hormone Signaling Pathway, 30000127$h_gleevecpathway:Inhibition of Cellular Proliferation by Gleevec, 30000145$h_ifngPathway:IFN gamma signaling pathway , 30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000157$h_il3Pathway:IL 3 signaling pathway, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells, 30000296$h_tidPathway:Chaperones modulate interferon Signaling Pathway, 30000301$h_TPOPathway:TPO Signaling Pathway]
Janus kinase 2,INTERPRO[450000257$IPR000299:FERM domain, 450000618$IPR000719:Protein kinase, core, 450000852$IPR000980:SH2 motif, 450001096$IPR001245:Tyrosine protein kinase, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008247$IPR009127:Janus kinase, JAK, 450008249$IPR009129:Janus kinase 2, JAK2, 450014575$IPR016251:Tyrosine-protein kinase, Jak/Tyk2, 450015769$IPR017441:Protein kinase, ATP binding site, 450017984$IPR019747:FERM conserved site, 450017986$IPR019749:Band 4.1 domain]
Janus kinase 2,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038866$hsa04630:Jak-STAT signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway]
Janus kinase 2,OMIM_DISEASE[520000707$Budd-Chiari syndrome, 520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease, 520002836$Leukemia, acute myelogenous, 520003462$Myelofibrosis, idiopathic, 520003471$Myeloproliferative disorder with erythrocytosis, 520004041$Polycythemia vera, 520004822$Thrombocythemia, essential]
Janus kinase 2,PIR_SUPERFAMILY[630000748$PIRSF000636:tyrosine-protein kinase, Jak/Tyk2 type, 630000749$PIRSF000636:TyrPK_Jak]
Janus kinase 2,SMART[760000192$SM00219:TyrKc, 760000224$SM00252:SH2, 760000266$SM00295:B41]
Janus kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000446$disease mutation, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001397$SH2 domain, 790001547$transferase, 790001586$tyrosine-protein kinase]
Janus kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850067567$chain:Tyrosine-protein kinase JAK2, 850103760$domain:FERM, 850105087$domain:Protein kinase 1, 850105088$domain:Protein kinase 2, 850105349$domain:SH2; atypical, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117925$site:Breakpoint for translocation to form PCM1-JAK2 fusion protein, 850118575$strand, 850118624$turn]
La ribonucleoprotein domain family, member 1,COG_ONTOLOGY[90000100$Posttranslational modification, protein turnover, chaperones / Translation, ribosomal structure and biogenesis]
La ribonucleoprotein domain family, member 1,INTERPRO[450006027$IPR006607:Protein of unknown function DM15, 450006049$IPR006630:RNA-binding protein Lupus La, 450010816$IPR011991:Winged helix repressor DNA-binding]
La ribonucleoprotein domain family, member 1,SMART[760000594$SM00684:DM15, 760000622$SM00715:LA]
La ribonucleoprotein domain family, member 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001339$rna-binding]
La ribonucleoprotein domain family, member 1,UP_SEQ_FEATURE[850027814$chain:La-related protein 1, 850102573$compositionally biased region:Poly-Gly, 850104168$domain:HTH La-type RNA-binding, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
POTE ankyrin domain family, member F,COG_ONTOLOGY[90000073$General function prediction only]
POTE ankyrin domain family, member F,INTERPRO[450001870$IPR002110:Ankyrin, 450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
POTE ankyrin domain family, member F,SMART[760000220$SM00248:ANK, 760000240$SM00268:ACTIN]
POTE ankyrin domain family, member F,SP_PIR_KEYWORDS[790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat]
POTE ankyrin domain family, member F,UP_SEQ_FEATURE[850040223$chain:POTE ankyrin domain family member F, 850106258$modified residue, 850110840$region of interest:Actin-like, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict]
SRY (sex determining region Y)-box 10,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 10,OMIM_DISEASE[520003945$PCWH, 520005060$Waardenburg syndrome, type IIE, 520005064$Waardenburg-Shah syndrome, 520005134$Yemenite deaf-blind hypopigmentation syndrome]
SRY (sex determining region Y)-box 10,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000415$deafness, 790000446$disease mutation, 790000466$dna-binding, 790000693$hirschsprung disease, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation, 790001636$Waardenburg syndrome]
SRY (sex determining region Y)-box 10,UP_SEQ_FEATURE[850065304$chain:Transcription factor SOX-10, 850102573$compositionally biased region:Poly-Gly, 850102920$DNA-binding region:HMG box, 850106258$modified residue, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal]
WD repeat domain 82,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 82,SMART[760000289$SM00320:WD40]
WD repeat domain 82,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 82,UP_SEQ_FEATURE[850100782$chain:WD repeat-containing protein 82, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6]
activating transcription factor 5,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
activating transcription factor 5,PIR_SUPERFAMILY[630016200$PIRSF019614:cyclic AMP-dependent transcription factor, ATF4 type]
activating transcription factor 5,SMART[760000306$SM00338:BRLZ]
activating transcription factor 5,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
activating transcription factor 5,UP_SEQ_FEATURE[850012982$chain:Cyclic AMP-dependent transcription factor ATF-5, 850102580$compositionally biased region:Poly-Pro, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850112729$region of interest:Interaction with PTP4A1, 850117294$sequence conflict, 850117295$sequence variant]
adenosine deaminase, tRNA-specific 3, TAD3 homolog (S. cerevisiae),INTERPRO[450001883$IPR002125:CMP/dCMP deaminase, zinc-binding, 450014525$IPR016192:APOBEC/CMP deaminase, zinc-binding]
adenosine deaminase, tRNA-specific 3, TAD3 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001572$trna processing, 790001648$zinc]
adenosine deaminase, tRNA-specific 3, TAD3 homolog (S. cerevisiae),UP_SEQ_FEATURE[850066825$chain:tRNA-specific adenosine deaminase-like protein 3, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117295$sequence variant]
alpha-kinase 3,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003676$IPR004166:MHCK/EF2 kinase, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
alpha-kinase 3,SMART[760000356$SM00408:IGc2, 760000713$SM00811:Alpha_kinase]
alpha-kinase 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790000825$kinase, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001388$serine/threonine-protein kinase, 790001547$transferase]
alpha-kinase 3,UP_SEQ_FEATURE[850004886$chain:Alpha-protein kinase 3, 850102565$compositionally biased region:Poly-Ala, 850102576$compositionally biased region:Poly-Leu, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850102883$disulfide bond, 850103039$domain:Alpha-type protein kinase, 850104200$domain:Ig-like 1, 850104264$domain:Ig-like 2, 850117295$sequence variant]
ankyrin repeat domain 24,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 24,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 24,UP_SEQ_FEATURE[850005380$chain:Ankyrin repeat domain-containing protein 24, 850102580$compositionally biased region:Poly-Pro, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117295$sequence variant, 850118574$splice variant]
armadillo repeat containing 1,INTERPRO[450000194$IPR000225:Armadillo, 450014939$IPR016617:Uncharacterised conserved protein UCP013899, metal binding]
armadillo repeat containing 1,PIR_SUPERFAMILY[630011354$PIRSF013899:UCP013899, 630011355$PIRSF013899:uncharacterized conserved protein]
armadillo repeat containing 1,SMART[760000159$SM00185:ARM]
armadillo repeat containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
armadillo repeat containing 1,UP_SEQ_FEATURE[850006116$chain:Armadillo repeat-containing protein 1, 850106258$modified residue, 850115673$repeat:ARM]
chromosome 1 open reading frame 38,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 38,UP_SEQ_FEATURE[850047978$chain:Protein THEMIS2, 850102462$compositionally biased region:Asp/Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 19 open reading frame 35,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 19 open reading frame 35,UP_SEQ_FEATURE[850055246$chain:Putative uncharacterized protein C19orf35]
chromosome 6 open reading frame 201,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 6 open reading frame 201,UP_SEQ_FEATURE[850074363$chain:Uncharacterized protein C6orf201, 850117295$sequence variant, 850118574$splice variant]
cytochrome P450, family 2, subfamily S, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 2, subfamily S, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450007404$IPR008067:Cytochrome P450, E-class, group I, CYP2A-like, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 2, subfamily S, polypeptide 1,KEGG_PATHWAY[470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450]
cytochrome P450, family 2, subfamily S, polypeptide 1,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 2, subfamily S, polypeptide 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000885$liver, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism]
cytochrome P450, family 2, subfamily S, polypeptide 1,UP_SEQ_FEATURE[850013753$chain:Cytochrome P450 2S1, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant, 850118574$splice variant]
dipeptidyl-peptidase 9,INTERPRO[450001220$IPR001375:Peptidase S9, prolyl oligopeptidase active site region, 450002189$IPR002469:Peptidase S9B, dipeptidylpeptidase IV N-terminal]
dipeptidyl-peptidase 9,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000069$Aminopeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001252$Protease, 790001383$Serine protease]
dipeptidyl-peptidase 9,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850015216$chain:Dipeptidyl peptidase 9, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dynactin 1 (p150, glued homolog, Drosophila),BIOCARTA[30000173$h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development]
dynactin 1 (p150, glued homolog, Drosophila),INTERPRO[450000819$IPR000938:Cytoskeleton-associated protein, CAP-Gly]
dynactin 1 (p150, glued homolog, Drosophila),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 1 (p150, glued homolog, Drosophila),OMIM_DISEASE[520000291$Amyotrophic lateral sclerosis, susceptibility to, 520003611$Neuropathy, distal hereditary motor, type VIIB, 520003965$Perry syndrome]
dynactin 1 (p150, glued homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000475$dynein, 790000960$microtubule, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
dynactin 1 (p150, glued homolog, Drosophila),UP_SEQ_FEATURE[850016476$chain:Dynactin subunit 1, 850102597$compositionally biased region:Ser-rich, 850103282$domain:CAP-Gly, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
dysbindin (dystrobrevin binding protein 1) domain containing 1,INTERPRO[450006885$IPR007531:Dysbindin]
dysbindin (dystrobrevin binding protein 1) domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
dysbindin (dystrobrevin binding protein 1) domain containing 1,UP_SEQ_FEATURE[850016553$chain:Dysbindin domain-containing protein 1, 850117294$sequence conflict, 850118574$splice variant]
frizzled homolog 5 (Drosophila),INTERPRO[450000019$IPR000024:Frizzled cysteine-rich domain, 450000462$IPR000539:Frizzled protein, 450013966$IPR015526:Frizzled related, 450016289$IPR017981:GPCR, family 2-like]
frizzled homolog 5 (Drosophila),KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038907$hsa05217:Basal cell carcinoma]
frizzled homolog 5 (Drosophila),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000428$developmental protein, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane, 790001642$wnt signaling pathway]
frizzled homolog 5 (Drosophila),UP_SEQ_FEATURE[850020051$chain:Frizzled-5, 850102883$disulfide bond, 850104018$domain:FZ, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117571$short sequence motif:Lys-Thr-X-X-X-Trp motif, 850117634$short sequence motif:PDZ-binding, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
histocompatibility (minor) HA-1,INTERPRO[450000169$IPR000198:RhoGAP, 450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding]
histocompatibility (minor) HA-1,SMART[760000047$SM00055:FCH, 760000096$SM00109:C1, 760000293$SM00324:RhoGAP]
histocompatibility (minor) HA-1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000640$GTPase activation, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
histocompatibility (minor) HA-1,UP_SEQ_FEATURE[850031774$chain:Minor histocompatibility protein HA-1, 850105183$domain:Rho-GAP, 850106258$modified residue, 850108265$peptide:Minor histocompatibility antigen HA-1, 850117295$sequence variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
katanin p60 (ATPase-containing) subunit A 1,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450013857$IPR015415:Vps4 oligomerisation, C-terminal]
katanin p60 (ATPase-containing) subunit A 1,SMART[760000335$SM00382:AAA]
katanin p60 (ATPase-containing) subunit A 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000743$hydrolase, 790000960$microtubule, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein]
katanin p60 (ATPase-containing) subunit A 1,UP_SEQ_FEATURE[850027067$chain:Katanin p60 ATPase-containing subunit A1, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112461$region of interest:Interaction with KATNB1, 850112540$region of interest:Interaction with microtubule, 850118574$splice variant]
leucine rich repeat and fibronectin type III domain containing 3,COG_ONTOLOGY[90000070$Function unknown]
leucine rich repeat and fibronectin type III domain containing 3,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450003484$IPR003961:Fibronectin, type III, 450006486$IPR007110:Immunoglobulin-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
leucine rich repeat and fibronectin type III domain containing 3,SMART[760000007$SM00013:LRRNT, 760000051$SM00060:FN3, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2]
leucine rich repeat and fibronectin type III domain containing 3,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001304$repeat, 790001405$signal, 790001475$synapse, 790001555$transmembrane]
leucine rich repeat and fibronectin type III domain containing 3,UP_SEQ_FEATURE[850028315$chain:Leucine-rich repeat and fibronectin type- III domain-containing protein 3, 850102883$disulfide bond, 850103799$domain:Fibronectin type-III, 850104199$domain:Ig-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
major vault protein,INTERPRO[450002218$IPR002499:Major vault protein, N-terminal]
major vault protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001325$ribonucleoprotein, 790001554$translocation, 790001558$transport]
major vault protein,UP_SEQ_FEATURE[850030236$chain:Major vault protein, 850105852$helix, 850106258$modified residue, 850116392$repeat:MVP 1, 850116393$repeat:MVP 2, 850116394$repeat:MVP 3, 850116395$repeat:MVP 4, 850116396$repeat:MVP 5, 850116397$repeat:MVP 6, 850116398$repeat:MVP 7, 850116399$repeat:MVP 8, 850116400$repeat:MVP 9, 850117295$sequence variant, 850118575$strand]
megakaryoblastic leukemia (translocation) 1,INTERPRO[450002665$IPR003034:DNA-binding SAP, 450003537$IPR004018:RPEL repeat]
megakaryoblastic leukemia (translocation) 1,OMIM_DISEASE[520003118$Megakaryoblastic leukemia, acute]
megakaryoblastic leukemia (translocation) 1,SMART[760000456$SM00513:SAP, 760000614$SM00707:RPEL]
megakaryoblastic leukemia (translocation) 1,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
megakaryoblastic leukemia (translocation) 1,UP_SEQ_FEATURE[850032202$chain:MKL/myocardin-like protein 1, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850105257$domain:SAP, 850106258$modified residue, 850113384$region of interest:Mediates interaction with SCAI and ACTB, 850116934$repeat:RPEL 1, 850116935$repeat:RPEL 2, 850117295$sequence variant, 850117933$site:Breakpoint for translocation to form RBM15-MKL1]
methyltransferase like 9,INTERPRO[450007232$IPR007884:DREV methyltransferase]
methyltransferase like 9,PIR_SUPERFAMILY[630018961$PIRSF023615:PIRSF023615]
methyltransferase like 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790001405$signal]
methyltransferase like 9,UP_SEQ_FEATURE[850031573$chain:Methyltransferase-like protein 9, 850102565$compositionally biased region:Poly-Ala, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
mitochondrial ribosome recycling factor,INTERPRO[450002361$IPR002661:Ribosome recycling factor, 450014401$IPR016000:Ribosome recycling factor, metazoan]
mitochondrial ribosome recycling factor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001255$protein biosynthesis, 790001550$transit peptide]
mitochondrial ribosome recycling factor,UP_SEQ_FEATURE[850058068$chain:Ribosome-recycling factor, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
nucleophosmin/nucleoplasmin, 2,INTERPRO[450003812$IPR004301:Nucleoplasmin]
nucleophosmin/nucleoplasmin, 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus]
nucleophosmin/nucleoplasmin, 2,UP_SEQ_FEATURE[850035209$chain:Nucleoplasmin-2, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys]
otopetrin 1,INTERPRO[450004352$IPR004878:Otopetrin]
otopetrin 1,SP_PIR_KEYWORDS[790000183$biomineralization, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001555$transmembrane]
otopetrin 1,UP_SEQ_FEATURE[850036291$chain:Otopetrin-1, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
polymerase (RNA) I polypeptide B, 128kDa,COG_ONTOLOGY[90000115$Transcription]
polymerase (RNA) I polypeptide B, 128kDa,INTERPRO[450006494$IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6, 450006495$IPR007121:RNA polymerase, beta subunit, conserved site, 450006999$IPR007641:RNA polymerase Rpb2, domain 7, 450007000$IPR007642:RNA polymerase Rpb2, domain 2, 450007001$IPR007644:RNA polymerase, beta subunit, protrusion, 450007002$IPR007645:RNA polymerase Rpb2, domain 3, 450007004$IPR007647:RNA polymerase Rpb2, domain 5, 450008767$IPR009674:RNA polymerase I, Rpa2 specific, 450014147$IPR015712:DNA-directed RNA polymerase, subunit 2]
polymerase (RNA) I polypeptide B, 128kDa,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038815$hsa03020:RNA polymerase]
polymerase (RNA) I polypeptide B, 128kDa,PIR_SUPERFAMILY[630000885$PIRSF000765:DNA-directed RNA polymerase 132K polypeptide]
polymerase (RNA) I polypeptide B, 128kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000468$dna-directed rna polymerase, 790000937$metal-binding, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
polymerase (RNA) I polypeptide B, 128kDa,UP_SEQ_FEATURE[850016040$chain:DNA-directed RNA polymerase I subunit RPA2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118762$zinc finger region:C4-type]
protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin),INTERPRO[450000255$IPR000297:Peptidyl-prolyl cis-trans isomerase, PpiC-type]
protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000052$alternative promoter usage, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000466$dna-binding, 790000810$Isomerase, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001343$Rotamase, 790001592$ubl conjugation]
protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin),UP_SEQ_FEATURE[850037672$chain:Peptidyl-prolyl cis-trans isomerase NIMA- interacting 4, 850105063$domain:PpiC, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850113569$region of interest:Necessary for association with the pre- rRNP complexes, 850113676$region of interest:Necessary for nuclear localization and DNA-binding, 850118574$splice variant, 850118575$strand, 850118624$turn]
retinoid X receptor, beta,INTERPRO[450000002$IPR000003:Retinoid X receptor, 450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
retinoid X receptor, beta,KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038906$hsa05216:Thyroid cancer, 470038912$hsa05222:Small cell lung cancer, 470038913$hsa05223:Non-small cell lung cancer]
retinoid X receptor, beta,PIR_SUPERFAMILY[630002651$PIRSF002534:retinoic X receptor-like nuclear receptor, 630031000$PIRSF500848:retinoid X receptor (RXR)]
retinoid X receptor, beta,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
retinoid X receptor, beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
retinoid X receptor, beta,UP_SEQ_FEATURE[850057417$chain:Retinoic acid receptor RXR-beta, 850102586$compositionally biased region:Pro-rich, 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850111880$region of interest:Hinge, 850113269$region of interest:Ligand-binding, 850113461$region of interest:Modulating, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F,INTERPRO[450001441$IPR001627:Semaphorin/CD100 antigen, 450001920$IPR002165:Plexin, 450003205$IPR003659:Plexin/semaphorin/integrin, 450013952$IPR015512:Seamphorin 4F, 450014355$IPR015943:WD40/YVTN repeat-like]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F,PIR_SUPERFAMILY[630005453$PIRSF005526:semaphorin]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F,SMART[760000369$SM00423:PSI, 760000545$SM00630:Sema]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001016$neurogenesis, 790001405$signal, 790001555$transmembrane]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F,UP_SEQ_FEATURE[850059304$chain:Semaphorin-4F, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105091$domain:PSI, 850105337$domain:Sema, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
sialic acid binding Ig-like lectin 11,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
sialic acid binding Ig-like lectin 11,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
sialic acid binding Ig-like lectin 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
sialic acid binding Ig-like lectin 11,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850060684$chain:Sialic acid-binding Ig-like lectin 11, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117519$short sequence motif:ITIM motif, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
sperm associated antigen 4-like,INTERPRO[450011595$IPR012919:Sad1/UNC-like, C-terminal]
sperm associated antigen 4-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
sperm associated antigen 4-like,UP_SEQ_FEATURE[850061837$chain:Sperm-associated antigen 4-like protein, 850105414$domain:SUN, 850117295$sequence variant]
taste receptor, type 2, member 40,INTERPRO[450007304$IPR007960:Mammalian taste receptor]
taste receptor, type 2, member 40,KEGG_PATHWAY[470038880$hsa04742:Taste transduction]
taste receptor, type 2, member 40,SP_PIR_KEYWORDS[790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001487$Taste, 790001546$transducer, 790001555$transmembrane]
taste receptor, type 2, member 40,UP_SEQ_FEATURE[850063578$chain:Taste receptor type 2 member 40, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
vacuolar protein sorting 13 homolog A (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
vacuolar protein sorting 13 homolog A (S. cerevisiae),INTERPRO[450008641$IPR009543:Vacuolar protein sorting-associated protein]
vacuolar protein sorting 13 homolog A (S. cerevisiae),OMIM_DISEASE[520001007$Choreoacanthocytosis]
vacuolar protein sorting 13 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000509$epilepsy, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001537$tpr repeat, 790001558$transport]
vacuolar protein sorting 13 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850099894$chain:Vacuolar protein sorting-associated protein 13A, 850106258$modified residue, 850117119$repeat:TPR 1, 850117120$repeat:TPR 10, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
versican,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000373$IPR000436:Sushi/SCR/CCP, 450000461$IPR000538:Link, 450000637$IPR000742:EGF-like, type 3, 450001149$IPR001304:C-type lectin, 450001663$IPR001881:EGF-like calcium-binding, 450002094$IPR002353:Type II antifreeze protein, 450003160$IPR003599:Immunoglobulin subtype, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450006486$IPR007110:Immunoglobulin-like, 450011699$IPR013032:EGF-like region, conserved site, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014444$IPR016060:Complement control module, 450014523$IPR016186:C-type lectin-like, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016659$IPR018378:C-type lectin, conserved site]
versican,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs)]
versican,OMIM_DISEASE[520005065$Wagner syndrome 1]
versican,PIR_SUPERFAMILY[630002392$PIRSF002268:proteoglycan link protein, 630009173$PIRSF010350:chicken chondroitin sulfate proteoglycan PG-M core protein]
versican,SMART[760000024$SM00032:CCP, 760000026$SM00034:CLECT, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000357$SM00409:IG, 760000391$SM00445:LINK]
versican,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000252$cataract, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000530$extracellular matrix, 790000616$glycoprotein, 790000735$hyaluronic acid, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001471$sushi, 790001555$transmembrane]
versican,UP_SEQ_FEATURE[850100205$chain:Versican core protein, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850104407$domain:Ig-like V-type, 850104724$domain:Link 1, 850104725$domain:Link 2, 850105415$domain:Sushi, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111730$region of interest:GAG-alpha (glucosaminoglycan attachment domain), 850111731$region of interest:GAG-beta, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
zinc finger protein 830,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type]
zinc finger protein 830,SP_PIR_KEYWORDS[790000012$acetylation, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000937$metal-binding, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 830,UP_SEQ_FEATURE[850101947$chain:Zinc finger protein 830, 850106258$modified residue, 850117295$sequence variant, 850118655$zinc finger region:C2H2-type]
zinc finger, BED-type containing 1,INTERPRO[450003202$IPR003656:Zinc finger, BED-type predicted, 450008146$IPR008906:HAT dimerisation]
zinc finger, BED-type containing 1,SMART[760000543$SM00614:ZnF_BED]
zinc finger, BED-type containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001648$zinc, 790001651$zinc-finger]
zinc finger, BED-type containing 1,UP_SEQ_FEATURE[850101281$chain:Zinc finger BED domain-containing protein 1, 850105852$helix, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118647$zinc finger region:BED-type]
